» Articles » PMID: 17591933

The Human Androgen Receptor X-chromosome Inactivation Assay for Clonality Diagnostics of Natural Killer Cell Proliferations

Overview
Journal J Mol Diagn
Publisher Elsevier
Date 2007 Jun 27
PMID 17591933
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Clonality is a frequently exploited characteristic of lymphoid malignancies. However, in the natural killer (NK) cell subset of large granular lymphocyte proliferations, clonality is difficult to prove because of the lack of specific genetic markers, such as immunoglobulin or T-cell receptor gene rearrangements. The human androgen receptor (HUMARA) assay, a polymerase chain reaction-based X-chromosome inactivation assay, is a potential diagnostic tool in these disorders. Although there is much experience with X-chromosome inactivation assays in myeloid proliferations, these assays have found only very limited application in clonality assessment of NK cell proliferations. We applied the HUMARA assay in laboratory diagnostics for detection of clonality in NK cell proliferations. We describe its test performance and report three cases in which clonality of NK cell populations was investigated by use of this assay. Our results demonstrate the usefulness of the HUMARA assay in the diagnostic workup of NK cell proliferations.

Citing Articles

Unfavorable switching of skewed X chromosome inactivation leads to Menkes disease in a female infant.

Matsumoto A, Kano S, Kobayashi N, Matsuki M, Furukawa R, Yamagishi H Sci Rep. 2024; 14(1):440.

PMID: 38172222 PMC: 10764769. DOI: 10.1038/s41598-023-50668-2.


Variability of cross-tissue X-chromosome inactivation characterizes timing of human embryonic lineage specification events.

Werner J, Ballouz S, Hover J, Gillis J Dev Cell. 2022; 57(16):1995-2008.e5.

PMID: 35914524 PMC: 9398941. DOI: 10.1016/j.devcel.2022.07.007.


Azacitidine is a potential therapeutic drug for pyridoxine-refractory female X-linked sideroblastic anemia.

Morimoto Y, Chonabayashi K, Kawabata H, Okubo C, Yamasaki-Morita M, Nishikawa M Blood Adv. 2021; 6(4):1100-1114.

PMID: 34781359 PMC: 8864662. DOI: 10.1182/bloodadvances.2021005664.


Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells.

Pastoret C, Desmots F, Drillet G, Le Gallou S, Boulland M, Thannberger A Blood. 2021; 137(23):3237-3250.

PMID: 33512451 PMC: 8351897. DOI: 10.1182/blood.2020006721.


Epigenomics and Single-Cell Sequencing Define a Developmental Hierarchy in Langerhans Cell Histiocytosis.

Halbritter F, Farlik M, Schwentner R, Jug G, Fortelny N, Schnoller T Cancer Discov. 2019; 9(10):1406-1421.

PMID: 31345789 PMC: 6795548. DOI: 10.1158/2159-8290.CD-19-0138.


References
1.
Nash R, McSweeney P, Zambello R, Semenzato G, Loughran Jr T . Clonal studies of CD3- lymphoproliferative disease of granular lymphocytes. Blood. 1993; 81(9):2363-8. View

2.
Allen R, Zoghbi H, Moseley A, Rosenblatt H, Belmont J . Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet. 1992; 51(6):1229-39. PMC: 1682906. View

3.
Gale R, Wheadon H, Boulos P, Linch D . Tissue specificity of X-chromosome inactivation patterns. Blood. 1994; 83(10):2899-905. View

4.
Kelly A, Richards S, Sivakumaran M, Shiach C, Stewart A, Roberts B . Clonality of CD3 negative large granular lymphocyte proliferations determined by PCR based X-inactivation studies. J Clin Pathol. 1994; 47(5):399-404. PMC: 502013. DOI: 10.1136/jcp.47.5.399. View

5.
Mutter G, Boynton K . PCR bias in amplification of androgen receptor alleles, a trinucleotide repeat marker used in clonality studies. Nucleic Acids Res. 1995; 23(8):1411-8. PMC: 306870. DOI: 10.1093/nar/23.8.1411. View